Caco-2 replace or refine?

Drug Discovery Today: Technologies - Tập 1 - Trang 423-430 - 2004
Anna-Lena B. Ungell1
1DMPK and Bioanalytical Chemistry, AstraZeneca R&D, S-431 83 Mölndal, Sweden

Tài liệu tham khảo

Ungell, 2003, Cell cultures in drug discovery: an industrial perspective, 90

Artursson, 1996, Caco-2 monolayers in experimental and theoretical predictions of drug transport, Adv. Drug. Deliv. Rev., 22, 67, 10.1016/S0169-409X(96)00415-2

Schwab, 2003, Comparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discovery, J. Med. Chem., 46, 1716, 10.1021/jm021012t

Kansy, 1998, Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption process, J. Med. Chem., 41, 1007, 10.1021/jm970530e

Ottiger, 1999, Immobilised artificial membrane (IAM)–HPLC for partition studies of neutral and ionised acids and bases in comparison with the liposomal partition system, Pharm. Res., 16, 643, 10.1023/A:1018808104653

Camenisch, 1997, Comparison of passive drug transport through Caco-2 cells and artificial membranes, Int. J. Pharm., 147, 61, 10.1016/S0378-5173(96)04796-5

Oprea, 2002, ChemGPS/VolSurf: a pharmacokinetically based mapping device for chemical space, J. Comb. Chem., 4, 258, 10.1021/cc010093w

Lipinski, 1996, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv. Drug Deliv. Rev., 23, 3, 10.1016/S0169-409X(96)00423-1

Egan, 2002, Prediction of intestinal permeability, Adv. Drug Deliv. Rev., 54, 273, 10.1016/S0169-409X(02)00004-2

Norinder, 2003, Calculated molecular properties and multivariate statistical analysis in absorption, 358

Ano, 2004, Relationships between structure and high-throughput screening permeability of peptide derivatives and related compounds with artificial membranes: application to prediction of Caco-2 cell permeability, Bioorg. Med. Chem., 12, 257, 10.1016/j.bmc.2003.10.002

Parrott, 2002, Prediction of intestinal absorption: comparative assessment of GASTROPLUS™ and iDEA™, Eur. J. Pharm. Sci., 17, 51, 10.1016/S0928-0987(02)00132-X

Gebauer, 2003, Three dimensional quantitative structure–activity relationship analyses of peptide susbstrates of the mammalian H+/peptide cotransporter PEPT1, J. Med. Chem., 46, 5725, 10.1021/jm030976x

Nordqvist, 2004, A general model for prediction of Caco-2 cell permeability, QSAR Comb. Sci., 23, 303, 10.1002/qsar.200330868

Van de Waterbeemd, 1996, Estimation of Caco-2 cell permeability using calculated molecular descriptors, Quant. Struct. Act. Relat., 15, 480, 10.1002/qsar.19960150604

Palm, 1997, Polar molecular surface properties predict the intestinal absorption of drugs in humans, Pharm. Res., 14, 568, 10.1023/A:1012188625088

Stenberg, 2001, Experimental and computational screening models for the prediction of intestinal drug absorption, J. Med. Chem., 44, 1927, 10.1021/jm001101a

Neuhoff, 2003, pH dependent bidirectional transport of weakly basic drugs across Caco-2 cell monolayers: implications for drug–drug interactions, Pharm. Res., 20, 1141, 10.1023/A:1025032511040

Anderle, 1998, P-glycoprotein (P-gp) mediated efflux in Caco-2 cell monolayers: the influence of culturing conditions and drug exposure on P-gp expression levels, J. Pharm. Sci., 87, 757, 10.1021/js970372e

Li, 2003, Influence of drugs and nutrients on gene expression levels in Caco-2 and LS180 intestinal epithelial cell lines, Pharm. Res., 20, 1119, 10.1023/A:1025076326061

Artursson, 1993, Selective paracellular permeability in two models of intestinal absorption: cultured monolayers of human intestinal epithelial cells and rat intestinal segments, Pharm. Res., 10, 1123, 10.1023/A:1018903931777

Karlsson, 1999, Paracellular drug transport across intestinal epithelia: influence of charge and induced water flux, Eur. J. Pharm. Sci., 9, 47, 10.1016/S0928-0987(99)00041-X

Hildalgo, 1990, Transport of a large neutral amino acid (phenyl alanine) in a human intestinal epithelial cell line: Caco-2, Biochim. Biophys. Acta, 1028, 25, 10.1016/0005-2736(90)90261-L

Augustijns, 2000, Hydration changes implicated in the remarkable temperature-dependent membrane permeation of cyclosporin A, Biochemistry, 39, 7621, 10.1021/bi9929709

Karlsson, 1991, A method for the determination of cellular permeability coefficients and aqueous boundary layer thickness in monolayers of intestinal epithelial (Caco-2) cells grown in permeable filter chambers, Int. J. Pharm., 71, 51, 10.1016/0378-5173(91)90067-X

Yamashita, 2000, Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells, Eur. J. Pharm. Sci., 10, 195, 10.1016/S0928-0987(00)00076-2

Krishna, 2001, Permeability of lipophilic compounds in drug discovery using in vitro human absorption model, Caco-2, Int. J. Pharm., 222, 77, 10.1016/S0378-5173(01)00698-6

Ingels, 2003, Biological, pharmaceutical and analytical considerations with respect to the transport media used in the absorption screening system, Caco-2. Minireviw, J. Pharm. Sci., 92, 1545, 10.1002/jps.10408

Taub, 2002, Optimized conditions for MDCK permeability and turbidimetric solubility studies using compounds representative of BCS classes I–IV, Eur. J. Pharm. Sci., 15, 331, 10.1016/S0928-0987(02)00015-5

Fisher, 1999, Midazolam metabolism by modified Caco-2 monolayers: effects of extracellular protein binding, J. Pharm. Exp. Ther., 289, 1143

Nerurkar, 1996, The use of surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polarized efflux system, Pharm. Res., 13, 528, 10.1023/A:1016033702220

Irvine, 1999, MDCK (Madin–Darby Canine Kidney) cells: a tool for membrane permeability screening, J. Pharm. Sci., 88, 28, 10.1021/js9803205

Raeissi, 1999, Interplay between CYP3A-mediated metabolism and polarized efflux of terfenadine and its metabolites in intestinal epithelial Caco-2 (TC-7) cell monolayers, Pharm. Res., 16, 625, 10.1023/A:1018851919674

Tavelin, 2003, Prediction of the oral absorption of low-permeability drugs using small intestine like 2/4/A1 cell monolayers, Pharm. Res., 20, 397, 10.1023/A:1022699920043

Kararli, 1995, Comparison of the gastrointestinal anatomy, physiology and biochemistry of humans and commonly used laboratory animals, Biopharm. Drug Dispos., 16, 351, 10.1002/bdd.2510160502

Ekins, 2002, Three-dimensional quantitative structure–activity relationships of inhibitors of P-glycoprotein, Mol. Pharmacol., 61, 964, 10.1124/mol.61.5.964

Goh, 2002, Endogenous drug transporters in in vitro and in vivo models for the prediction of drug disposition in man, Biochem. Pharmacol., 64, 1569, 10.1016/S0006-2952(02)01355-2

Troutman, 2003, Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium, Pharm. Res., 20, 1210, 10.1023/A:1025001131513

Bermejo, 2004, PAMPA – a drug absorption in vitro model: 7. Comparing rat in situ, Caco-2 and PAMPA permeability of fluoroquinolones, Eur. J. Pharm. Sci., 21, 429, 10.1016/j.ejps.2003.10.009

Artursson, 1997, Intestinal drug absorption and metabolism in cell cultures: Caco-2 and beyond, Pharm. Res., 14, 1655, 10.1023/A:1012155124489

Thông tin
Thông tin xuất bản

Drug Discovery Today: Technologies

Tập 1

423-430

Thông tin tác giả